Pfizer Inc (PFE)

$25.81 +0.40 (1.57%)
Market Cap 144.82B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.14
Forward PE 8.43
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 47,058,300
Avg Vol 43,589,973
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 100%
Beta 0.34
Analysts Sell
Price Target $28.70

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Andrew100x
Andrew100x Aug. 6 at 3:51 AM
$PFE let it ride!
0 · Reply
SandraHolmes870
SandraHolmes870 Aug. 6 at 3:35 AM
$ARWR $MOVE $MGNI $DVN $PFE Arrowhead advances RNA interference therapies, MOVE remains execution-driven, Magnite benefits from connected TV advertising, Devon Energy generates disciplined energy cash flow, and Pfizer continues advancing its pharmaceutical pipeline.
1 · Reply
AlbertoDostie1011
AlbertoDostie1011 Aug. 6 at 3:26 AM
$PFE $RDW $PSKY $NLST $TQQQ Pfizer advances its pharmaceutical pipeline, Redwire expands space infrastructure, PSKY remains execution-driven, Netlist benefits from memory demand, and TQQQ amplifies Nasdaq gains.
0 · Reply
thebrockettman
thebrockettman Aug. 6 at 12:51 AM
$PFE Buy now for the 6.66% divy!! 😈😈
1 · Reply
NEWBIGTECH
NEWBIGTECH Aug. 5 at 11:10 PM
$SLS Part 3. No Open Market purchases after J.P Morgan 1x1 meetings with $JNJ and $PFE . Cluster purchases came before J.P Morgan 1x1 because all insiders and independent BOD have MNPI. Negotiations have been going on under strict NDA/MOU since December 2025. Now you all understand why we voted 3 million shares in favor of Dr. Stergiou stock award. We want Dr. Stergiou aligned with Comon Retail folks here that have been longs for a very long time. Dr. Stergiou has 1,875,000 reasons to Negotiate the best BO! ✌️🙏❤️‍🩹
2 · Reply
lihsus
lihsus Aug. 5 at 10:01 PM
$PFE finally an insider bought $1 million worth of shares in open market
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 5 at 9:42 PM
$PFE The assholes are playing with fire. LOL
0 · Reply
CestrianCapitalResearch
CestrianCapitalResearch Aug. 5 at 9:21 PM
$PFE Commitment to free: headlines, ratings, ranges are before the paywall, nuance and detail afterwards. On our site right now.
2 · Reply
BullMaven
BullMaven Aug. 5 at 8:27 PM
$PFE nice solid close
0 · Reply
Vivani_Medical
Vivani_Medical Aug. 5 at 8:23 PM
Great to see $VANI CEO Adam Mendelsohn, PhD, featured in Stocktwits' Boardroom Exclusives series, talking about Vivani's recently announced agreement with $NVO . Check out the full video at https://x.com/ST_BoardroomX/status/2081756970567049267?s=20 $NVO $LLY $PFE
0 · Reply
Latest News on PFE
Pfizer price target raised to $27 from $26 at BofA

2026-08-05T10:45:23.000Z - 17 hours ago

Pfizer price target raised to $27 from $26 at BofA

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 1 day ago

Pfizer Earnings Call Transcript: Q2 2026

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 1 day ago

Pfizer Earnings release: Q2 2026

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 1 day ago

Pfizer Slides: Q2 2026

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 1 day ago

Pfizer Quarterly report: Q2 2026

Pfizer Stock (PFE) Falls on 2026 Sales Outlook as Cancer Drugs Fuel Q2 Beat

2026-08-04T11:39:45.000Z - 1 day ago

Pfizer Stock (PFE) Falls on 2026 Sales Outlook as Cancer Drugs Fuel Q2 Beat

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 1 day ago

Pfizer Post Loss on Higher Revenue

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:13 AM EDT - 1 day ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

Aug 4, 2026, 7:12 AM EDT - 1 day ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Pfizer reports Q2 adjusted EPS 77c, consensus 68c

2026-08-04T10:52:17.000Z - 1 day ago

Pfizer reports Q2 adjusted EPS 77c, consensus 68c

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:52 AM EDT - 1 day ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Pfizer backs FY26 adjusted EPS view $2.80-$3.00, consensus $2.95

2026-08-04T10:51:36.000Z - 1 day ago

Pfizer backs FY26 adjusted EPS view $2.80-$3.00, consensus $2.95

Pfizer announces expansion of productivity enhancement Initiatives

2026-08-04T10:50:31.000Z - 1 day ago

Pfizer announces expansion of productivity enhancement Initiatives

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Aug 4, 2026, 6:45 AM EDT - 1 day ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

5 Things to Know Before the Stock Market Opens on Monday

Aug 3, 2026, 8:10 AM EDT - 2 days ago

5 Things to Know Before the Stock Market Opens on Monday

AMD AZN BMY CAT CVS DASH DIS

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 7:48 AM EDT - 6 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Pfizer says LITFULO studies meet co-primary endpoints

2026-07-30T11:03:18.000Z - 6 days ago

Pfizer says LITFULO studies meet co-primary endpoints

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 30, 2026, 6:45 AM EDT - 6 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

EC authorizes Pfizer, BioNTech XFG-adapted COVID-19 vaccine in EU

2026-07-29T20:42:19.000Z - 7 days ago

EC authorizes Pfizer, BioNTech XFG-adapted COVID-19 vaccine in EU

BNTX

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

Jul 29, 2026, 4:30 PM EDT - 7 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:48 PM EDT - 14 days ago

Pfizer's prostate cancer drug combination gets US FDA priority review

FDA grants priority review for Pfizer’s Talzena plus Xtandi

2026-07-22T20:40:37.000Z - 14 days ago

FDA grants priority review for Pfizer’s Talzena plus Xtandi

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 22, 2026, 4:30 PM EDT - 14 days ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

Jul 21, 2026, 7:10 PM EDT - 15 days ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 16, 2026, 1:39 PM EDT - 20 days ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 10, 2026, 11:23 AM EDT - 26 days ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 4 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

Jun 29, 2026, 4:43 PM EDT - 5 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 29, 2026, 1:20 AM EDT - 5 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 6 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 2:10 PM EDT - 6 weeks ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 6 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 12:10 PM EDT - 6 weeks ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 23, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 6 weeks ago

Pfizer's experimental drug misses main goal of lung cancer trial

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 4:30 PM EDT - 6 weeks ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

Jun 22, 2026, 2:32 PM EDT - 6 weeks ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 6 weeks ago

Pfizer CFO Dave Denton to step down, leave company in August

Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 6 weeks ago

Pfizer Announces Chief Financial Officer Transition

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 29, 2026, 8:00 AM EDT - 2 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 11:10 PM EDT - 2 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:19 PM EDT - 2 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 27, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 9:00 AM EDT - 2 months ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:08 AM EDT - 2 months ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

May 20, 2026, 5:05 AM EDT - 2 months ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

Andrew100x
Andrew100x Aug. 6 at 3:51 AM
$PFE let it ride!
0 · Reply
SandraHolmes870
SandraHolmes870 Aug. 6 at 3:35 AM
$ARWR $MOVE $MGNI $DVN $PFE Arrowhead advances RNA interference therapies, MOVE remains execution-driven, Magnite benefits from connected TV advertising, Devon Energy generates disciplined energy cash flow, and Pfizer continues advancing its pharmaceutical pipeline.
1 · Reply
AlbertoDostie1011
AlbertoDostie1011 Aug. 6 at 3:26 AM
$PFE $RDW $PSKY $NLST $TQQQ Pfizer advances its pharmaceutical pipeline, Redwire expands space infrastructure, PSKY remains execution-driven, Netlist benefits from memory demand, and TQQQ amplifies Nasdaq gains.
0 · Reply
thebrockettman
thebrockettman Aug. 6 at 12:51 AM
$PFE Buy now for the 6.66% divy!! 😈😈
1 · Reply
NEWBIGTECH
NEWBIGTECH Aug. 5 at 11:10 PM
$SLS Part 3. No Open Market purchases after J.P Morgan 1x1 meetings with $JNJ and $PFE . Cluster purchases came before J.P Morgan 1x1 because all insiders and independent BOD have MNPI. Negotiations have been going on under strict NDA/MOU since December 2025. Now you all understand why we voted 3 million shares in favor of Dr. Stergiou stock award. We want Dr. Stergiou aligned with Comon Retail folks here that have been longs for a very long time. Dr. Stergiou has 1,875,000 reasons to Negotiate the best BO! ✌️🙏❤️‍🩹
2 · Reply
lihsus
lihsus Aug. 5 at 10:01 PM
$PFE finally an insider bought $1 million worth of shares in open market
0 · Reply
AIIAAIIA_88
AIIAAIIA_88 Aug. 5 at 9:42 PM
$PFE The assholes are playing with fire. LOL
0 · Reply
CestrianCapitalResearch
CestrianCapitalResearch Aug. 5 at 9:21 PM
$PFE Commitment to free: headlines, ratings, ranges are before the paywall, nuance and detail afterwards. On our site right now.
2 · Reply
BullMaven
BullMaven Aug. 5 at 8:27 PM
$PFE nice solid close
0 · Reply
Vivani_Medical
Vivani_Medical Aug. 5 at 8:23 PM
Great to see $VANI CEO Adam Mendelsohn, PhD, featured in Stocktwits' Boardroom Exclusives series, talking about Vivani's recently announced agreement with $NVO . Check out the full video at https://x.com/ST_BoardroomX/status/2081756970567049267?s=20 $NVO $LLY $PFE
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 5 at 8:23 PM
$PFE ALBERT TAKE NOTES LOOK AT THIS DO THIS
1 · Reply
breakawayrider
breakawayrider Aug. 5 at 8:10 PM
$PFE OMG, OMG - 2 insider buys!!! first in ~18 months!
0 · Reply
Andrew100x
Andrew100x Aug. 5 at 8:08 PM
$PFE told you 🚀 I feel bad because i rolled over my weeklies couldve made some if held a lil longer. But LET IT RIDE
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Aug. 5 at 8:07 PM
$PFE - Ronald supremacy
1 · Reply
FilingTracker
FilingTracker Aug. 5 at 8:04 PM
$PFE Insider opened new position: https://filingtracker.ai/filing/78003/0001225208-26-006943?doc=doc4.xml
1 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Aug. 5 at 8:01 PM
$PFE nice! Closing at the high of the day is always a welcomed sight and plenty more to come - slow and steady grind upward from here!
0 · Reply
JBS_84
JBS_84 Aug. 5 at 7:59 PM
$PFE Thing went nuts last minute and crossed the 200 day ema and the 50 week. Pretty crazy. We will see if it lasts. Probably be some pullbacks but the trend is in good shape.
1 · Reply
BB_88_
BB_88_ Aug. 5 at 7:58 PM
$PFE send it
0 · Reply
Cutlass
Cutlass Aug. 5 at 7:54 PM
$PFE Holding 👍
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Aug. 5 at 7:52 PM
$PFE I dont think weve climbed into the close as long as ive been here...
2 · Reply
MrPeanutEsquire
MrPeanutEsquire Aug. 5 at 7:46 PM
$PFE Pfizer? Are you ok?
1 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 5 at 7:17 PM
$PFE It's better than 24.50... I guess
0 · Reply